Brainstorm Cell Therapeutics Inc. Share Price
Equities
BCLI
US10501E2019
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5345 USD | +0.47% | +0.47% | +95.79% |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 36.53M 2.92B |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.68B | Net income 2025 * | -27M -2.16B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-1.43
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.75% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | +0.47% | ||
1 week | +0.47% | ||
Current month | -5.35% | ||
1 month | -19.02% | ||
3 months | +68.61% | ||
6 months | +231.99% | ||
Current year | +95.79% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 30/06/07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 22/12/12 |
Chief Tech/Sci/R&D Officer | - | 11/05/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 21/09/00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 05/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 29/03/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.5345 | +0.47% | 266,201 |
25/04/24 | 0.532 | -2.39% | 274,960 |
24/04/24 | 0.545 | +3.81% | 201,949 |
23/04/24 | 0.525 | -2.80% | 169,719 |
22/04/24 | 0.5401 | +1.52% | 367,454 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.79% | 36.53M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BCLI Stock